Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 32 (1), 170-172
- https://doi.org/10.1016/0006-2952(83)90673-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.JCI Insight, 1982
- Sulfasalazine Inhibits the Absorption of Folates in Ulcerative ColitisNew England Journal of Medicine, 1981
- Chemotaxis and Random Migration of Polymorphonuclear Leukocytes in Ulcerative Colitis Examined by the Agarose MethodScandinavian Journal of Gastroenterology, 1981
- TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMASThe Lancet, 1981
- Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial.BMJ, 1981
- Leukotriene B4: A highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytesActa Physiologica Scandinavica, 1980
- Increased chemotactic activity of neutrophil leukocytes in psoriasisBritish Journal of Dermatology, 1980
- The Effect of Sulfasalazine and Its Active Components on Human Polymorphonuclear Leukocyte Function in Relation to Ulcerative ColitisActa Medica Scandinavica, 1979
- PROSTAGLANDINS, ULCERATIVE COLITIS, AND SULPHASALAZINEThe Lancet, 1975
- Salazopyrin, a new sulfanilamide preparation. A. Therapeutic Results in Rheumatic Polyarthritis. B. Therapeutic Results in Ulcerative Colitis. C. Toxic Manifestations in Treatment with Sulfanilamide Preparations.Acta Medica Scandinavica, 1942